QDEL
QuidelOrtho Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$13.97
+0.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.7B | 2.7B | 2.8B | 3.0B | 3.3B |
| Cost of Revenue | 1.5B | 1.5B | 1.5B | 1.5B | 1.3B |
| Gross Profit | 1.2B | 1.3B | 1.3B | 1.5B | 1.9B |
| Operating Expenses | |||||
| R&D Expense | 180.9M | 186.2M | 218.7M | 246.8M | 187.9M |
| SG&A Expense | 770.3M | 746.3M | 766.8M | 763.2M | 621.0M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 1.1B | 1.3B | 2.3B | 349.8M | 283.6M |
| Total Operating Expenses | 2.0B | 2.2B | 3.2B | 1.4B | 1.1B |
| Cost and Expenses | 3.5B | 3.6B | 4.7B | 2.9B | 2.4B |
| Operating Income (EBIT) | (820.3M) | (919.2M) | (2.0B) | 139.1M | 843.7M |
| Non-Operating | |||||
| Interest Income | 4.0M | — | — | 2.2M | 1.3M |
| Interest Expense | 195.0M | 177.6M | 188.3M | 178.9M | 74.5M |
| Net Interest Income | (191.2M) | (177.6M) | (188.9M) | (176.7M) | (73.2M) |
| Other Non-Op Income/Expense | (209.7M) | (188.5M) | (170.6M) | (168.2M) | (107.8M) |
| Non-Operating Income (excl Interest) | 16.1M | 10.9M | (17.7M) | (10.7M) | 33.3M |
| EBT (Pre-Tax Income) | (1.0B) | (1.1B) | (2.1B) | (29.1M) | 735.9M |
| Income Tax Expense | 18.4M | 24.1M | (79.5M) | (19.0M) | 187.2M |
| Bottom Line | |||||
| Net Income | (1.0B) | (1.1B) | (2.1B) | (10.1M) | 548.7M |
| Earnings from Cont. Ops | (1.0B) | (1.1B) | (2.1B) | (10.1M) | 548.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.0B) | (1.1B) | (2.1B) | (10.1M) | 548.7M |
| Per Share | |||||
| Basic EPS | ($15.44) | ($16.69) | ($30.54) | ($0.15) | $9.66 |
| Diluted EPS | ($15.44) | ($16.69) | ($30.54) | ($0.15) | $9.56 |
| Revenue Per Share | $39.15 | $40.27 | $41.41 | $44.88 | $57.50 |
| Shares | |||||
| Basic Shares Outstanding | 68.3M | 67.8M | 67.2M | 66.8M | 56.8M |
| Diluted Shares Outstanding | 68.3M | 67.8M | 67.2M | 66.8M | 57.4M |
| Profitability Metrics | |||||
| EBITDA | (498.9M) | (488.1M) | (1.5B) | 607.0M | 1.1B |
| D&A | 337.5M | 442.0M | 453.4M | 457.2M | 283.6M |
| EBIT | (836.4M) | (930.1M) | (1.9B) | 149.8M | 810.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026